Table 1.

Phase 2 Study Patient Characteristics

 
Total no. of patients 17 
Mean age (range) 57.1 yr (23-74) 
Gender (male/female) 13/4 
Performance status (Karnofsky) 
100% 10 
90% 0 
80% 7 
Tumor type 
Renal cell cancer 17 
Prior therapy 
IL-2 14 
Surgery 17 
 
Total no. of patients 17 
Mean age (range) 57.1 yr (23-74) 
Gender (male/female) 13/4 
Performance status (Karnofsky) 
100% 10 
90% 0 
80% 7 
Tumor type 
Renal cell cancer 17 
Prior therapy 
IL-2 14 
Surgery 17 
View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal